MoneyWorks4Me

Cadila Healthcare inform about outcome of board meeting

09 Jul 2021 Evaluate

Cadila Healthcare has informed that Ganesh N. Nayak (DIN00017481) was appointed as the Whole Time Director and Chief Operating Officer of the Company for a period of 1 year with effect from July 12, 2020 and his term will expire on July 11, 2021. The Board of Directors at their meeting held today July 9, 2021, based on the recommendation of the Nomination and Remuneration Committee, approved re-appointment of Ganesh N. Nayak, as the Executive Director of the Company for a period of 3 years with effect from July 12, 2021. He shall be liable to retire by rotation. The said re-appointment shall be subject to approval of the shareholders at the ensuing Annual General Meeting by way of an Ordinary Resolution. Ganesh N. Nayak is not related to any of the Directors of the Company. He is not debarred from holding the office of director pursuant to any SEBI Order or any other authority. Brief profile of Ganesh N. Nayak is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..